Cautious news tone
News Sentiment
RGC sentiment intelligence
Regencell Bioscience Holdings Ltd news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Cautious news tone is being confirmed by negative weekly price action.
77/100 classification confidence.
directly relevant articles
high-authority source matches
-36.2% over one week, -53.4% over four weeks, trend inactive, and materially above fair value.
Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Market Reaction
Caution confirmed by price
Cautious news tone is being confirmed by negative weekly price action.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Regencell Bioscience Holdings Ltd. (NASDAQ: RGC) and some of its officers. The lawsuit seeks to recover damages for investors who purchased Regencell securities between October 28, 2024, and October 31, 2
- Tone
- Negative 14/100
- Event
- Regulatory and legal
- Published
- 22 Jun 2026 16:10
- Source
- Carroll County Mirror-Democrat
RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Regencell Bioscience Holdings Ltd. to Contact the Firm Today!
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Regencell Bioscience Holdings Ltd. (NASDAQ:RGC) on behalf of investors who purchased securities between October 28, 2024, and October 31, 2025. The lawsuit alleges that Regencell made false and misleading
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 19 Jun 2026 23:47
- Source
- ACCESS Newswire
RGC DEADLINE: The Gross Law Firm Reminds Regencell
The Gross Law Firm is reminding investors of Regencell Bioscience Holdings Limited (NASDAQ: RGC) about an upcoming securities class action deadline of June 23, 2026. The lawsuit alleges that Regencell issued materially false and misleading statements during the period of October
- Tone
- Negative 14/100
- Event
- Regulatory and legal
- Published
- 19 Jun 2026 14:10
- Source
- GlobeNewswire
RGC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
Faruqi & Faruqi, LLP reminds investors of the June 23, 2026 deadline to seek lead plaintiff status in a securities class action lawsuit against Regencell Bioscience Holdings Limited (NASDAQ: RGC). The lawsuit alleges that Regencell and its executives made misleading statements re
- Tone
- Negative 30/100
- Event
- Regulatory and legal
- Published
- 19 Jun 2026 00:40
- Source
- Sahm
SueWallSt Reminds Regencell Bioscience Holdings Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of June 23, 2026 - RGC
SueWallSt is reminding investors of Regencell Bioscience Holdings Limited (NASDAQ: RGC) about a pending securities class action lawsuit with a lead plaintiff deadline of June 23, 2026. The lawsuit alleges misrepresentations about the company's financial health, specifically its $
- Tone
- Negative 13/100
- Event
- Regulatory and legal
- Published
- 18 Jun 2026 13:39
- Source
- PR Newswire
Regencell Bioscience Holdings Ltd (RGC) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of Regencell Bioscience Holdings Ltd (RGC) stock, focusing on its dividend history and stock split events. It notes that the company has distributed $0.00 in dividends over the past five years and lists one upcoming stock split event on June 2, 2
- Tone
- Negative 41/100
- Event
- Capital return
- Published
- 18 Jun 2026 09:39
- Source
- TradingKey
Regencell Bioscience Holdings Ltd (RGC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
This article provides an overview of Regencell Bioscience Holdings Ltd (RGC) stock performance, showing a recent close at $14.710 with a 12.07% decrease. It specifically states that the company has not yet disclosed relevant data regarding its revenue breakdown by business segmen
- Tone
- Negative 34/100
- Event
- Earnings
- Published
- 18 Jun 2026 05:19
- Source
- TradingKey
RGC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regencell Bioscience Holdings Securities Lawsuit - Contact Levi & Korsinsky
Levi & Korsinsky, LLP is alerting institutional investors who held Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares between October 28, 2024, and October 31, 2025, about a pending securities class action lawsuit. The lawsuit alleges that Regencell made misleading statem
- Tone
- Negative 26/100
- Event
- Regulatory and legal
- Published
- 18 Jun 2026 00:38
- Source
- Sahm
Regencell Bioscience (RGC) Sees Significant Decline in Stock Pri
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 17 Jun 2026 22:10
- Source
- GuruFocus
REGENCELL DEADLINE TUESDAY JUNE 23rd: Bragar Eagel &
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2026 22:09
- Source
- GlobeNewswire
Regencell Bioscience Holdings Ltd (RGC) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a detailed risk assessment for Regencell Bioscience Holdings Ltd (RGC), focusing on its volatility, financial risk, and investment risk. It presents various metrics such as Beta, VaR, Maximum Drawdown, Realized Volatility, and Sharpe Ratio over different per
- Tone
- Negative 30/100
- Event
- Market update
- Published
- 17 Jun 2026 21:09
- Source
- TradingKey
Regencell Bioscience Holdings Ltd (RGC) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of Regencell Bioscience Holdings Ltd (RGC), highlighting its current stock performance, market capitalization, and various technical indicators. It notes that RGC is currently showing strong sell signals based on both individual indicato
- Tone
- Negative 29/100
- Event
- Market update
- Published
- 17 Jun 2026 21:09
- Source
- TradingKey
RGC Stockholders Have Opportunity to Lead Regencell Bioscience Holdings Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Regencell Bioscience Holdings Ltd. (NASDAQ:RGC) and its officers. The lawsuit claims that Regencell made false and misleading statements regarding market manipulation and financial risk during the Cla
- Tone
- Negative 19/100
- Event
- Regulatory and legal
- Published
- 16 Jun 2026 23:09
- Source
- ACCESS Newswire
RGC Shareholder Alert: June 23, 2026 Lead Plaintiff Deadline in Regencell Bioscience Holdings Limited Securities Class Action - Contact The Gross Law Firm
The Gross Law Firm has issued a shareholder alert for Regencell Bioscience Holdings Limited (NASDAQ: RGC) regarding a securities class action lawsuit. Shareholders who purchased RGC shares between October 28, 2024, and October 31, 2025, are encouraged to contact the firm by the l
- Tone
- Negative 14/100
- Event
- Regulatory and legal
- Published
- 16 Jun 2026 13:09
- Source
- Barchart.com
RGC INVESTOR ALERT: Holzer & Holzer, LLC Reminds Investors
Holzer & Holzer, LLC has filed a class action lawsuit against Regencell Bioscience Holdings Limited (NASDAQ: RGC), alleging that the company made false and misleading statements and/or failed to disclose material adverse facts regarding its business, operations, and compliance po
- Tone
- Negative 14/100
- Event
- Regulatory and legal
- Published
- 16 Jun 2026 11:40
- Source
- GlobeNewswire
Regencell Bioscience Holdings (RGC) Stock Valuation After Securities Class Action Raises Fresh Concerns
Regencell Bioscience Holdings (RGC) is facing a class action lawsuit alleging securities law violations amidst sharp stock volatility, a 34.11% drop over 30 days, and a 68.62% decline over the last year. The company screens as very expensive with a Price-to-Book ratio of 7,651x d
- Tone
- Negative 18/100
- Event
- Regulatory and legal
- Published
- 16 Jun 2026 11:19
- Source
- Simply Wall Street
Portnoy Law Firm Announces Class Action on Behalf of Regencell Bioscience Holdings Limited Investors
The Portnoy Law Firm has announced a class action lawsuit against Regencell Bioscience Holdings Limited (NASDAQ: RGC) on behalf of investors who purchased securities between October 28, 2024, and October 31, 2025. The lawsuit alleges that Regencell made false and misleading state
- Tone
- Negative 14/100
- Event
- Regulatory and legal
- Published
- 16 Jun 2026 11:12
- Source
- GlobeNewswire
Regencell Bioscience Holdings Limited (RGC) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Glancy Prongay Wolke & Rotter LLP has announced an opportunity for shareholders of Regencell Bioscience Holdings Limited (RGC), who suffered losses, to lead a securities fraud class action lawsuit. The lawsuit alleges that Regencell failed to disclose its vulnerability to market
- Tone
- Negative 28/100
- Event
- Regulatory and legal
- Published
- 15 Jun 2026 18:39
- Source
- Barchart.com
Regencell Bioscience Holdings (RGC) Is Down 11.5% After DOJ Subpoena Spurs Class Actions Over Alleged Misstatements – Has The Bull Case Changed?
Regencell Bioscience Holdings (RGC) has seen an 11.5% stock drop following a Department of Justice subpoena and subsequent class-action lawsuits. The lawsuits allege the company made materially false statements and failed to disclose market manipulation vulnerability between Octo
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 10 Jun 2026 08:41
- Source
- Simply Wall Street
RGC STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit filed against Regencell Bioscience Holdings Ltd. (NASDAQ:RGC) and its officers. The lawsuit, on behalf of investors who purchased RGC securities between October 28, 2024, and October 31, 2025, alleges the com
- Tone
- Negative 16/100
- Event
- Regulatory and legal
- Published
- 09 Jun 2026 18:40
- Source
- ACCESS Newswire
RGC Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Regencell Bioscience Holdings Limited Securities Lawsuit - Contact The Gross Law Firm
The Gross Law Firm is notifying shareholders of Regencell Bioscience Holdings Limited (NASDAQ: RGC) about a class action lawsuit. Investors who purchased shares between October 28, 2024, and October 31, 2025, are encouraged to contact the firm regarding potential lead plaintiff a
- Tone
- Negative 18/100
- Event
- Regulatory and legal
- Published
- 09 Jun 2026 13:09
- Source
- Barchart.com
RGC Shareholder Alert: Regencell Bioscience Holdings Limited Securities Class Action Lawsuit - Investors Should Contact SueWallSt
SueWallSt has announced a securities class action lawsuit against Regencell Bioscience Holdings Limited (NASDAQ: RGC) for allegedly misleading investors between October 28, 2024, and October 31, 2025. The lawsuit claims Regencell's leadership was aware of the stock's vulnerabilit
- Tone
- Negative 15/100
- Event
- Regulatory and legal
- Published
- 08 Jun 2026 22:10
- Source
- Sahm
RGC Deadline: RGC Investors with Losses in Excess of $100K Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit
The Rosen Law Firm is reminding investors of Regencell Bioscience Holdings Limited (NASDAQ: RGC) who suffered losses exceeding $100K to consider acting as lead plaintiff in a securities fraud lawsuit. The deadline to move the Court to be appointed lead plaintiff is June 23, 2026.
- Tone
- Negative 5/100
- Event
- Regulatory and legal
- Published
- 07 Jun 2026 17:40
- Source
- Sahm
RGC Shareholder Alert: Regencell Bioscience Holdings Limited Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
- Tone
- Negative 18/100
- Event
- Regulatory and legal
- Published
- 02 Jun 2026 07:00
- Source
- Business Wire
Regencell (NASDAQ: RGC) director returns 19,000 stock options in issuer repurchase
- Tone
- Neutral 50/100
- Event
- Capital return
- Published
- 29 May 2026 07:00
- Source
- Stock Titan
What Are the Core Allegations Against Regencell Bioscience
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 23 May 2026 23:37
- Source
- Kavout
Regencell (RGC) raises $20M in registered direct stock offering
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 May 2026 07:00
- Source
- Stock Titan
RGC Deadline Alert: Levi & Korsinsky Reminds Regencell Bioscience Holdings (RGC) Investors of Securities Class Action Deadline on June 23, 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 20 May 2026 07:00
- Source
- Morningstar
Auditor Change Puts Regencell Bioscience Governance And Cash Runway In Focus
- Tone
- Neutral 50/100
- Event
- Balance sheet
- Published
- 27 Apr 2026 10:07
- Source
- Simply Wall St.
Regencell (RGC) Stock Fundamentally Speaking (Wavering) 2026-04-15 - ETF Outflow Streak
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Apr 2026 07:00
- Source
- lwvtexas.org